GTX Corp
117 West 9th Street
Suite 1214
Los Angeles
California
90015
United States
Tel: 213-489-3019
Fax: 213-489-3062
Website: http://www.gtxcorp.com/
Email: info@gtxcorp.com
58 articles about GTX Corp
-
GTX Issued Two Patents from USPTO
3/23/2022
GTX Corp(OTC: GTXO) (“the Company”), a pioneer in the field of health & safety wearable GPS human and asset tracking systems and personal protective medical equipment, announced today it has been issued two new patents by the United States Patent and Trademark Office (USPTO).
-
Halberd and GTX Corp. Sign Scientific Collaboration and Reseller Agreement
10/12/2021
Halberd Corporation (OTC PINK:HALB) and GTX Corp. (OTC PINK:GTXO) have agreed to work together on various neurodegenerative diseases such as Alzheimer's Disease, Parkinson's Disease, PTSD/CTE (Chronic Traumatic Encephalopathy)/ Traumatic Brain Injury), among others.
-
GTX Medical Appoints Dave Marver as Chief Executive Officer
7/2/2020
GTX Medical announced the appointment of Dave Marver as Chief Executive Officer.
-
GTX Corp Third Quarter 2017 Summary Results
11/20/2017
Product revenues increased by 7% over 2016 comparable period.
-
GTX Corp To Host Key Opinion Leader Luncheon On The Topic Of Stress Urinary Incontinence On September 28th In New York City
9/22/2017
-
GTX Corp Announces Positive Results From Enobosarm Phase II Proof-Of-Concept Clinical Trial In Women With Stress Urinary Incontinence
9/13/2017
-
GTX Corp Second Quarter 2017 Results
8/17/2017
-
GTX Corp Provides Corporate Update And Reports Second Quarter 2017 Financial Results
8/14/2017
-
GTX Corp Signs Collaboration Agreement With Veristride
8/10/2017
-
GTX Corp Provides Corporate Update And Reports First Quarter 2017 Financial Results
5/15/2017
-
GTX Corp Reports Results From Ongoing Enobosarm Phase 2 Clinical Trial In ER+/AR+ Breast Cancer
12/8/2016
-
GTX Corp Achieves Second Stage 1 Milestone In Phase 2 Clinical Trial Of Enobosarm In ER+/AR+ Breast Cancer
11/16/2016
-
GTX Corp Announces $14.0 Million Registered Direct Common Stock Offering
10/12/2016
-
GTX Corp Announces Initiation Of Phase 2 Clinical Trial Of Enobosarm In Stress Urinary Incontinence
1/13/2016
-
GTX Corp Receives FDA Clearance To Initiate Clinical Trial In Stress Urinary Incontinence
10/13/2015
-
GTX Corp Announces Enrollment Of First Patient In Phase 2 Clinical Trial Of Enobosarm In Triple Negative Breast Cancer
10/6/2015
-
GTX Corp Provides Corporate Update And Reports Second Quarter 2015 Financial Results
8/6/2015
-
GTX Corp Announces Webcast Of Corporate Presentation At Jefferies 2015 Global Healthcare Conference
5/26/2015
-
GTX Corp Announces Webcast Of Corporate Presentation At The UBS Global Healthcare Conference 2015
5/12/2015
-
GTX Corp Provides Corporate Update And Reports First Quarter 2015 Financial Results
5/8/2015